The human body is complex, and many things can go wrong while a baby is developing. Sometimes, genetic mutations occur, or things don’t form quite right. One condition that can result from ...

An optic nerve glioma is a type of noncancerous, slow-growing tumor that develops in the glial cells of the optic nerve. They are most common in children. Doctors may refer to this type of tumor as ...

Patients who took the frequently prescribed diabetes and weight-loss drugs Ozempic and Wegovy faced a greater risk of a stroke of the optic nerve, which can lead to blindness, according to a new study ...

A retrospective cohort study suggested that users of GLP-1 receptor agonists had a 7% higher incidence of new-onset diabetic retinopathy. In patients with existing diabetic retinopathy, use of GLP-1 ...

Multiple sclerosis (MS) is an autoimmune demyelinating disease of the central nervous system that commonly causes optic neuritis. While people with MS can initially recover from optic neuritis, over ...

Optic atrophy is a condition in which the optic nerve begins to deteriorate. The optic nerve is the nerve at the back of your eye that connects your eye to your brain, allowing you to see. There are a ...

The use of GLP-1 receptor agonists, and particularly liraglutide, was associated with an increased risk of developing nonarteritic anterior ischemic optic neuropathy (NAION) during the first year of ...

Please provide your email address to receive an email when new articles are posted on . SALT LAKE CITY — In this video, Christine Curcio, PhD, FARVO, discusses how her research into the role of drusen ...

PHOENIX — Historically, optic nerve involvement has been excluded from multiple sclerosis (MS) diagnostic criteria, but its inclusion in the upcoming 2024 McDonald Diagnostic Criteria is expected to ...

Please provide your email address to receive an email when new articles are posted on . Optic nerve fiber thickness improved among nearly all patients after SLT and resveratrol. The combination lowers ...

The risk of new-onset diabetic retinopathy (DR) increased slightly, but significantly, in patients taking GLP-1 receptor agonists for diabetes, despite a lower risk of vision-threatening complications ...